#USA #New York #Gross Law Firm #Geron Corporation #Rytelo

Class Action Lawsuit Announced Against Geron Corporation

On April 21, 2025, The Gross Law Firm issued a formal notice to shareholders of Geron Corporation (NASDAQ: GERN), alerting them about a class action lawsuit concerning potential losses incurred during a specific period. The case centers on allegations that Geron misled investors regarding the potential success and growth of its drug, Rytelo (imetelstat).

Background of the Case

The class action pertains to shareholders who purchased GERN shares between February 28, 2024, and February 25, 2025. During this timeframe, the defendants reportedly provided investors with optimistic expectations about Rytelo's launch and market potential which did not align with subsequent realities. They assured stakeholders of Geron's capability to address a significant unmet need through this drug, all while downplaying various risks related to its market penetration, including competition and the burden of monitoring that comes with the treatment.

The issue escalated on February 26, 2025, when Geron disclosed disappointing financial results for the fourth quarter of the fiscal year 2024. The announcement revealed a stagnation in the growth of Rytelo, prompting the company to attribute its lackluster performance to factors such as seasonality, competition, and a general lack of awareness regarding the drug's benefits. Consequently, this news triggered a remarkable drop in Geron's stock price, plummeting 32.07% in just one day, from $2.37 per share on February 25, 2025, to $1.61 on February 26.

How to Participate

Shareholders who are interested in being part of this class action should not hesitate to register. This is crucial as the deadline to seek lead plaintiff status is May 12, 2025. Participants in the class action will be provided with monitoring tools that deliver updates on the case's progression. It's important to note that potential participants do not need to be appointed as lead plaintiffs to benefit from any recovery that arises from the case.

To register, shareholders can fill out the necessary information through the provided link on The Gross Law Firm's website.

Why Gross Law Firm?

The Gross Law Firm is a well-regarded national firm focused on protecting investors' rights. It aims to represent those who have suffered financial losses due to misinformation, fraudulent activities, and unethical business practices. The firm's commitment lies in ensuring that companies maintain integrity in their operations, and they actively seek restoration for investors affected by misleading information that artificially inflates stock prices.

The law firm's outreach reflects its dedication to investor protection and a transparent legal process, reinforcing its mission to hold corporations accountable for their actions.

For shareholders looking to secure their interests in this lawsuit, immediate action is encouraged to navigate the complexities of this challenging legal landscape effectively. Interested parties should reach out to The Gross Law Firm without delay, as time is of the essence.

For further inquiries, you can contact The Gross Law Firm located at 15 West 38th Street, 12th floor, New York, NY, 10018, via phone at (646) 453-8903 or email at [email protected].

This class action represents an opportunity for affected shareholders of Geron Corporation to stand up against potential corporate malfeasance. Registering for participation could be pivotal in reclaiming lost investments stemming from misleading business practices and statements.